New York, NY- September 16, 2015 (PRWEB) September 17, 2015
“Our mission is to make breast aesthetics safer and better for women worldwide by delivering a world class technology platform that promotes women's health and enables the strategic adoption of Motiva as the brand of choice in the market,” said Juan José Chacón-Quirós, CEO of Establishment Labs. “The investment and partnership from Crown Predator and JW Asset Management and the global relationships and experience they provide will enable us to accelerate investment in our technology, grow our customer base, and scale our business to meet growing demand. We are excited to officially begin the journey to bring our next generation Motiva implants to the United States, the largest market for breast aesthetics in the world."
Today, thousands of patients and plastic surgeons in over 50 countries and across five continents are choosing Motiva implants that include exclusive capabilities like RFID microtransponders, fully biocompatible nanosurfaces, and TrueTissue™ dynamics for the look and feel of natural breasts, and an extended product guarantee through Lloyd's of London. Motiva implants have reported complication rates of less than 1% after 5 years of implantation.
“We see tremendous opportunities in the breast aesthetics market. After spending significant time analyzing the space and meeting with leading plastic surgeons, we found Motiva to be the leading technology brand that meets the demands of health-conscious women worldwide", said Nick Lewin, Managing Partner at Crown Predator Holdings. "Women deserve to have the best minds, both doctors and scientists, working on breast implant technology, and have a product that incorporates all the advancements in medical devices, surface technology, and silicon innovation over the past 25 years.
Jason Wild, President and Chief Investment Officer at JW Asset Management added, “The team at Establishment Labs is focused on delivering the highest quality products in the industry, including an advanced technology platform to provide a first class customer experience. Establishment Labs is poised to become a market leader in breast aesthetics and we are excited to be a part of this round of financing.”
About Establishment Labs
Establishment Labs is a global, privately held, aesthetic company that designs, develops, manufactures and markets an innovative product portfolio consisting of advanced silicone-filled breast (http://www.motivaimplants.com) and body shaping implants. Utilizing only the highest quality of medical grade silicones, the CE-marked Motiva Implant Matrix® line is rigorously scrutinized by professional Quality Engineers throughout the entire manufacturing process. All of its products are manufactured in full compliance with ISO and EU requirements, and are certified under the Medical Device Directive 93/42/EEC.
About Crown Predator Holdings
Crown Predator Holdings (CPH) invests in early and growth stage companies with an interest in special situations that do not easily fit into traditional investment categories. CPH leads and co-invests in transactions across all industries, capital structures, and styles. Through an extensive and global network of relationships and support, CPH seeks to add value as partners, not just as investors. Founded in 2006 and based in New York City, CPH is a family office led investment firm.
About JW Asset Management
JW Asset Management is a New York based fund manager for five investment partnerships. Jason Wild, a registered pharmacist, is the firm's founder and chief investment officer. JW Asset Management was founded in 1997 and has a strong history of finding opportunities within the specialty pharmaceutical sector. The firm is active in both the public and private equity markets.